Payer or Provider: Two Sides of the Same Coin?

Article

Payer or Provider: Two Sides of the Same Coin?

September 08, 2022
Authors
Topics

Welcome to the September 2022 edition of our Monthly Insight Series. This month we discuss our inaugural Payer Report Series, which is launching soon.

doctors

Greetings from San Mateo!

Our inaugural Payer Report Series is launching soon! The first report of this series, coming out later this month, will be a two-part payer landscape report featuring 1) a landscape overview and 2) in-depth yet succinct profiles on six of the largest vertical payers: Humana, Centene, Elevance Health (formerly Anthem), Cigna, UnitedHealth Group, and CVS Health. 

As these payers continue to grow and “verticalize,” they are capturing an increasingly large share of national healthcare expenditures and will impact how every stakeholder in our health system does business. But what exactly are they doing and how successful are their verticalization efforts? 

We combed through the data and financial sources to deliver a report sure to elevate our sponsors’ understanding of how each vertical payer’s overall structure, recent healthcare services investments, business size and footprint, and financial model will impact the overall organization. If you want to know how your company’s priorities and business operations need to adapt as these vertical payers grow, be sure to keep an eye on your inbox for the release of this incredibly valuable report!

Sneak Peek

UnitedHealth Group is arguably the most extensive and integrated vertical payer to date with a high “verticalization maturity” – the Optum Brand is more than a decade in the making and has a huge network of both employed healthcare practitioners and value-based provider arrangements

UnitedHealth is investing in oncology care services, with a focus on oncology value-based programs, dedicated Optum cancer clinics, the Optum Cancer Centers of Excellence program, and its Optum infusion pharmacies

Optum Insight sells extensive datasets and analytics offerings, helping to make Optum (for now) the leader in providing healthcare information among its vertical payer rivals

We can’t wait to share this report with you soon! As always, please reach out with any comments or questions you have.

All the best...
-- HMP Market Access Insights Team

The Latest

Podcast
Community Oncology Practice Economics - Podcast Part 3 of 3

In the final part of this 3-part podcast series, HMP Executive Vice President Lee Blansett and special guest John Hennessy—health system, provider and oncology strategist—explore emerging models for success in oncology practice economics.

Lee Blansett
Bispecific Antibodies: A Balancing Act of Promise and Complexity
Article
Bispecific Antibodies: A Balancing Act of Promise and Complexity

Bispecific antibodies have emerged with great promise, but adoption has been slower than expected. This was a key topic discussed by a panel of 5 experts at the October 2024 Association for Value-Based Cancer Care (AVBCC) conference.

Chris Van Denburg
Podcast
Community Oncology Practice Economics - Podcast Part 2 of 3

In part 2 of this 3-part podcast series, HMP Executive Vice President Lee Blansett and special guest John Hennessy—health system, provider and oncology strategist—explore the operational realities of oncology practice economics.

Lee Blansett